SNDL is the ticker symbol for SNDL Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks SNDL with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is SNDL a good stock to buy?

SNDL is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/SNDL.

Where does 13F Pro source SNDL data?

All SNDL Inc. fundamentals and ownership data come directly from SEC EDGAR. SNDL Inc. files with the SEC under CIK 1766600. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

SNDL Inc.(SNDL)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

SNDL Inc. (SNDL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SNDL is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of SNDL by reported 13-F value include MORGAN STANLEY, CANNELL CAPITAL, Toroso Investments, based on the most recent SEC filings. SNDL trades on the Nasdaq exchange and files with the SEC under CIK 1766600. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SNDL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SNDL Inc. directly from SEC EDGAR.

SNDL key financials by period

SNDL Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	40-F	$946.4M	—	—
FY 2024	40-F	$920.4M	—	—
FY 2023	40-F	$909.0M	—	—
FY 2022	20-F/A	$712.2M	—	—
FY 2021	20-F/A	$56.1M	—	—
FY 2020	20-F	$60.9M	—	—

Institutions holding SNDL

Institutional investors reporting a position in SNDL Inc. on SEC Form 13F.
Institution	Shares	Value	Reported
MORGAN STANLEY	10,214,013	$13.8M	2026-06-30
CANNELL CAPITAL	8,639,381	$11.7M	2026-06-30
Toroso Investments	5,334,370	$7.2M	2026-06-30
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	2,357,401	$3.2M	2026-06-30
CITADEL ADVISORS	2,165,081	$2.9M	2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP	2,116,500	$2.9M	2026-06-30
MIRAE ASSET GLOBAL ETFS Ltd.	2,113,976	$2.9M	2026-06-30
GOLDMAN SACHS GROUP	1,970,467	$2.7M	2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP	1,913,418	$2.6M	2026-06-30
Ewing Morris & Investment Partners Ltd.	1,481,222	$2.0M	2026-06-30

SEC EDGAR: CIK 1766600 →

SNDL Inc.

SNDL

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.